Characterization of an Escherichia coli -derived human papillomavirus type 16 and 18 bivalent vaccine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of an Escherichia coli -derived human papillomavirus type 16 and 18 bivalent vaccine

Published:2017-08 Issue:35 Volume:35 Page:4637-4645
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Gu Ying,Wei Minxi,Wang Daning,Li Zhihai,Xie Minghui,Pan Huirong,Wu Ting,Zhang Jun,Li Shaowei,Xia Ningshao

Funder

National Natural Science Foundation

National Key Projects in Science and Technology

Fujian Provincial Key Projects in Science and Technology

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference41 articles.

1. HPV-associated diseases;Ljubojevic;Clin Dermatol,2014

2. Against which human papillomavirus types shall we vaccinate and screen? The international perspective;Munoz;Int J Cancer,2004

3. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles;Zhou;Virology,1991

4. Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction;Baker;Biophys J,1991

5. Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids;Hagensee;J Virol,1994

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of a triple-type chimeric vaccine against human papillomavirus types 18, 45, and 59;Vaccine;2024-10

2. Unleashing the potential of mRNA: Overcoming delivery challenges with nanoparticles;Bioengineering & Translational Medicine;2024-08-15

3. A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen capture;2024-06-07

4. Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9–14 years of age: Interim analysis from a phase 3 clinical trial;Vaccine;2024-04

5. Development of a new vaccine at the laboratory scale;Bioreactor Design Concepts for Viral Vaccine Production;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3